Ophthalmology – Choroideremia
Choroideremia is a rare, progressive, X-linked inherited retinal disorder characterized by degeneration of the retinal pigment epithelium (RPE), choroid, and photoreceptors. It primarily affects males, while female carriers are usually asymptomatic or exhibit only mild findings. The disease leads to gradual vision loss over decades, eventually resulting in blindness.

Epidemiologically, choroideremia has an estimated prevalence of approximately 1 in 50,000 individuals. Because it is inherited in an X-linked recessive pattern, it predominantly affects males with a positive family history. Female carriers may occasionally show mild retinal changes but rarely develop significant visual impairment.
​
The underlying genetic defect involves mutations in the CHM gene located on the X chromosome (Xq21.2). This gene encodes the Rab escort protein (REP-1), which is essential for intracellular vesicle transport and normal RPE function. Loss of REP-1 disrupts cellular processes such as phagocytosis of photoreceptor outer segments, lysosomal activity, and intracellular trafficking. These abnormalities ultimately lead to progressive degeneration of the RPE, followed by secondary loss of photoreceptors and choroidal structures.
Clinically, affected males typically present with night blindness (nyctalopia), often beginning in childhood or adolescence. This is followed by progressive peripheral vision loss, initially manifesting as annular scotomas and eventually leading to concentric visual field constriction. By around 40 years of age, many patients have severe peripheral vision loss approaching legal blindness, although central visual acuity is often preserved until later in life.
On examination, early fundus findings include pigmentary changes and patchy areas of RPE and choroidal atrophy in the mid-periphery. As the disease progresses, these areas coalesce, exposing the underlying sclera and leaving only small islands of functioning retina, typically around the macula and optic disc. In advanced stages, the retina appears markedly thinned with extensive choroidal loss.
Diagnosis is primarily clinical but can be confirmed with genetic testing. Functional testing such as visual field analysis and electroretinography (ERG) is useful for assessing disease severity and progression. ERG initially shows a rod-cone degeneration pattern and eventually becomes non-recordable in advanced disease. Imaging modalities such as fluorescein angiography may demonstrate areas of capillary non-perfusion corresponding to atrophic regions.
​
There is currently no definitive treatment for choroideremia. Management focuses on monitoring disease progression and supportive care. Emerging therapies, particularly gene therapy aimed at restoring REP-1 function, show promise but remain under investigation. Patients may benefit from low vision rehabilitation as visual function declines. Protective measures such as UV-blocking sunglasses may help reduce additional retinal stress.

Genetic counseling is an essential component of care, given the X-linked inheritance pattern. Families should be educated about transmission risks, including the 50% chance of carrier mothers passing the mutation to offspring. Prenatal testing may be considered in affected families.

The prognosis involves progressive visual decline. Most affected males develop severe peripheral vision loss by midlife and eventual loss of central vision later in life, leading to blindness. Female carriers generally have a much milder course.

Complications primarily relate to progressive vision loss and its functional consequences, including reduced independence and quality of life. Posterior subcapsular cataracts may also develop in some patients and can be managed surgically if needed.

​

​


Ophthalmology – Choroidal Rupture


Choroidal rupture is a traumatic break involving the choroid, Bruch’s membrane, and the retinal pigment epithelium (RPE), typically resulting from blunt ocular trauma. The injury occurs when the globe is rapidly compressed and then expands, causing mechanical stress that exceeds the tensile strength of Bruch’s membrane. While the sclera and retina are relatively elastic and resistant, Bruch’s membrane is more brittle and prone to tearing.


Epidemiologically, blunt ocular trauma is the most common type of eye injury, and approximately 5–10% of such cases result in choroidal rupture. Most patients have a single rupture, although multiple ruptures can occur in up to 25% of cases. The majority are located temporal to the optic disc, and about two-thirds involve the macula. Although rare in the general population, choroidal rupture is more frequently encountered in individuals with a history of ocular trauma.


The primary risk factor is blunt trauma to the eye, often occurring in younger individuals, particularly males. Patients with pre-existing abnormalities of Bruch’s membrane, such as angioid streaks, are more susceptible and may develop ruptures even after relatively minor trauma. Preventive measures include the use of protective eyewear, especially during contact sports or high-risk activities.


Pathophysiologically, trauma causes rupture of Bruch’s membrane and damage to the underlying choriocapillaris, leading to subretinal or sub-RPE hemorrhage. In the acute phase, hemorrhage and retinal edema may obscure the rupture. As the hemorrhage resolves, the rupture becomes visible as a characteristic white, curvilinear streak, often concentric to the optic disc. Choroidal ruptures are classified as direct (at the site of impact) or indirect (away from the impact site, typically in the posterior pole).


Clinically, patients usually present with a history of blunt trauma followed by decreased vision, central or paracentral scotoma, or visual distortion. On examination, findings may include subretinal hemorrhage and, later, the classic crescent-shaped streak. Additional traumatic findings such as retinal tears, macular holes, or retinal detachment may also be present and should be actively sought.


Diagnosis is primarily clinical but supported by imaging. Fluorescein angiography typically shows an early hypofluorescent streak followed by late hyperfluorescence. Indocyanine green angiography can help identify ruptures obscured by hemorrhage. Optical imaging and B-scan ultrasonography may assist in evaluating associated complications. CT imaging may be required if there is concern for orbital fractures or intraocular foreign bodies.


There is no direct treatment for the rupture itself. Management focuses on identifying and treating associated injuries and complications. Inflammation may be treated with topical steroids and cycloplegics. A key long-term complication is choroidal neovascularization (CNV), which may develop months to years later and is typically treated with anti-VEGF therapy.


Prognosis depends largely on the location of the rupture. Subfoveal ruptures are associated with poor visual outcomes, whereas extrafoveal ruptures often preserve good vision unless complicated by CNV. Many patients do not achieve visual acuity better than 20/40, particularly if the macula is involved.


Complications include CNV (the most common late complication), retinal detachment, and persistent visual field defects. Patients should be monitored closely over time and educated to use tools such as an Amsler grid to detect early visual changes suggestive of CNV development.

Ophthalmology – Choroidal Nevus
Choroidal nevus is the most common intraocular tumor and represents a benign melanocytic lesion arising within the uveal tract, most commonly in the choroid. It typically appears as a pigmented (brown in about 80% of cases) or less commonly nonpigmented lesion. Most nevi are small, measuring approximately 2 mm in diameter and 1.5 mm in thickness, and may be associated with overlying retinal pigment epithelium (RPE) changes such as drusen, hyperplasia, or atrophy. Although benign, careful evaluation is essential to differentiate it from choroidal melanoma.

Epidemiologically, choroidal nevus is far more common in Caucasians, particularly those with blue eyes. The overall prevalence is estimated to be around 7% in Caucasian adults, with increasing detection rates with age. Although believed to be present from birth, most nevi are identified later in life when pigmentation develops or during routine dilated fundus examinations. It affects both genders equally, though some studies suggest a slight female predominance.

Risk factors primarily include fair skin and light-colored eyes, reflecting a predisposition in individuals with less ocular pigmentation. There is no known hereditary pattern or genetic predisposition, and no established method of prevention. The exact pathophysiology and etiology remain unknown, although it is considered a benign proliferation of melanocytes within the choroid. 

Most patients with a choroidal nevus are asymptomatic, with approximately 84% having no visual complaints. A minority may experience decreased vision, flashes, floaters, or visual field defects depending on the lesion’s location, particularly if it involves the macula. On examination, the lesion appears as a flat or minimally elevated pigmented area, commonly located outside the fovea. 

Diagnosis is primarily clinical, supported by multimodal imaging. Fundus photography helps document size and location, while ultrasonography assesses thickness. Optical coherence tomography (OCT) is useful for detecting subretinal fluid or retinal changes overlying the nevus. Fluorescein and indocyanine green angiography can evaluate vascular characteristics, and autofluorescence imaging helps assess RPE health. These tools are also critical for monitoring stability over time.

A key aspect of management is distinguishing benign nevi from lesions at risk of malignant transformation. Risk factors suggesting possible progression to melanoma can be remembered with the mnemonic “To Find Small Ocular Melanoma Using Helpful Hints Daily,” which includes thickness greater than 2 mm, subretinal fluid, symptoms, orange pigment, proximity to the optic disc, ultrasound hollowness, absence of halo, and absence of drusen. Lesions with multiple risk factors warrant closer observation or referral.

There is no medical treatment for choroidal nevus. Management typically consists of observation with periodic follow-up every 3–6 months initially, then biannually if stable. Imaging is repeated to detect any growth or development of suspicious features. Intervention is considered only if there is documented growth or complications such as subretinal fluid affecting vision, which may prompt treatments similar to those used for melanoma.

The prognosis is excellent for stable lesions without growth. Visual outcome depends largely on location; extrafoveal lesions usually preserve vision, whereas subfoveal nevi may lead to visual decline. The main complication is rare transformation into choroidal melanoma, as well as potential vision loss if the lesion affects the macula.

​

Ophthalmology – Choroidal Neovascularization
Choroidal neovascularization (CNV) refers to the formation of abnormal new blood vessels originating from the choroid that penetrate through defects in Bruch’s membrane into the subretinal space. These vessels often form a fibrovascular complex that is fragile and prone to leakage, leading to accumulation of fluid, lipid exudation, and hemorrhage. Over time, this process can result in the formation of a disciform scar and permanent vision loss. CNV is not a standalone disease but a complication of many underlying disorders affecting the retinal pigment epithelium (RPE)–Bruch’s membrane–choriocapillaris complex.
​
Epidemiologically, the incidence and prevalence of CNV vary depending on the underlying condition. It is most commonly associated with age-related macular degeneration (AMD), which is the leading cause of irreversible vision loss in individuals over 65 years in developed countries. Advanced AMD affects tens of millions of people worldwide. The likelihood of developing CNV increases significantly with age and is influenced by systemic and genetic factors.

Risk factors depend largely on the underlying disease. In AMD-related CNV, advancing age, smoking, hypertension, hyperlipidemia, obesity, and reduced physical activity play significant roles. A strong family history also increases risk, reflecting a genetic predisposition. Genetic studies, including twin studies and genome-wide analyses, support the multifactorial inheritance pattern of AMD and its complications such as CNV.

The pathophysiology involves disruption of Bruch’s membrane, which allows neovascular tissue from the choriocapillaris to grow into the subretinal space. This process is driven by proangiogenic factors such as vascular endothelial growth factor (VEGF), platelet-derived growth factor, and other inflammatory mediators. CNV can be classified based on its location relative to the RPE, including type 1 (sub-RPE), type 2 (subretinal), or mixed forms.
Clinically, patients typically present with sudden onset of decreased central vision, often accompanied by metamorphopsia and paracentral scotomas. On examination, findings may include RPE elevation, subretinal fluid, lipid exudates, hemorrhage, and a gray-green lesion beneath the retina. These features reflect the leakage and instability of the neovascular membrane.

Diagnosis is primarily made using imaging techniques. Fluorescein angiography helps identify leakage patterns and differentiate between classic and occult CNV. Optical coherence tomography (OCT) is essential for detecting structural changes such as subretinal fluid, intraretinal edema, and RPE detachment, and is also useful for monitoring response to treatment.

Management has evolved significantly with the advent of anti-VEGF therapy, which is now the standard of care. Intravitreal injections of agents such as ranibizumab or bevacizumab inhibit neovascular growth and reduce leakage, often stabilizing or improving vision. In selected cases, particularly extrafoveal lesions or non-AMD etiologies, laser photocoagulation or photodynamic therapy may be considered. Surgical options such as vitrectomy are reserved for complications like submacular hemorrhage.
​
The prognosis depends on the location of the lesion and the extent of damage at presentation. Early detection and treatment significantly improve visual outcomes. However, recurrence is common, requiring ongoing monitoring with tools such as the Amsler grid and serial imaging.

Complications include subretinal fibrosis, persistent or recurrent fluid accumulation, and, in severe cases, massive subretinal hemorrhage that can lead to retinal detachment and profound vision loss.

​

Ophthalmology – Choroidal Melanoma
Choroidal melanoma is the most common primary intraocular malignancy, arising from melanocytes within the uveal tract. The majority of cases (about 90%) involve the choroid, with smaller proportions affecting the iris or ciliary body. These tumors may appear pigmented, nonpigmented, or mixed, and typically present as dome-shaped, mushroom-shaped, or diffuse lesions. They are often associated with subretinal fluid, orange pigment (lipofuscin), and occasionally hemorrhage. Any suspicious pigmented lesion in the fundus must be carefully evaluated for possible melanoma.

Epidemiologically, choroidal melanoma most commonly occurs in middle-aged adults, with a median age of around 55 years. It is more prevalent in fair-skinned, blue-eyed individuals, particularly those with a tendency to sunburn. The incidence in the United States is approximately 4–6 cases per million in Caucasians and lower in other populations. Although rare in children, it can occur in all age groups. Approximately 2,500 new cases are diagnosed annually in the United States.

Risk factors include light skin pigmentation, oculodermal melanocytosis (Nevus of Ota), and preexisting choroidal nevi with high-risk features such as increased thickness, subretinal fluid, symptoms, and the presence of orange pigment. Genetic studies have shown that chromosomal abnormalities, particularly monosomy 3 and duplication of chromosome 8q, are associated with a worse prognosis and increased risk of metastasis.

The pathophysiology involves malignant transformation of melanocytes within the choroid. These tumors may arise de novo or from preexisting benign lesions such as choroidal nevi. As the tumor grows, it can disrupt surrounding structures, leading to retinal detachment, photoreceptor damage, and vision loss.

Clinically, patients may present with decreased vision, flashes, floaters, or may remain asymptomatic in early stages. On examination, the tumor typically appears as a pigmented or amelanotic mass, most commonly located in the posterior segment. Associated findings may include subretinal fluid, retinal detachment, and lipofuscin deposits. The lesion’s size, location, and proximity to the optic disc or fovea are important in determining prognosis and management.

Diagnosis relies on clinical examination and multimodal imaging. Fundus photography, ultrasonography, fluorescein angiography, indocyanine green angiography, and optical coherence tomography are commonly used. Ultrasonography is particularly useful in identifying the internal acoustic characteristics of the tumor. In selected cases, fine needle aspiration biopsy may be performed to confirm diagnosis and evaluate cytogenetic markers. Systemic evaluation, including liver function tests and imaging such as liver MRI or PET scan, is essential to detect metastasis, as the liver is the most common site of spread.

Management depends on tumor size, location, and patient factors. Treatment options include plaque radiotherapy, proton beam therapy, surgical resection, transpupillary thermotherapy, and enucleation. Plaque radiotherapy and proton beam therapy are commonly used for small to medium-sized tumors and offer high rates of local tumor control. Enucleation is reserved for large tumors or those with complications such as glaucoma or extraocular extension.
​
Prognosis is closely related to tumor size and genetic features. The risk of metastasis increases with tumor thickness, ranging from approximately 12% for small tumors to 50% for large tumors at 10 years. Despite effective local control, metastatic disease significantly worsens survival. Visual outcomes depend on tumor location and treatment modality, with many patients experiencing vision loss after radiotherapy.
​
Complications vary depending on treatment. Enucleation may result in cosmetic and socket-related issues, while radiotherapy can lead to radiation retinopathy, optic neuropathy, cataract, glaucoma, and eventual loss of the eye. Lifelong follow-up is essential to monitor for recurrence and systemic metastasis.

​

Ophthalmology – Choroidal Hemangioma
Choroidal hemangioma is a benign vascular tumor of the choroid composed of abnormal blood vessels. It exists in two main forms: circumscribed choroidal hemangioma (CCH), which is a localized solitary lesion without systemic associations, and diffuse choroidal hemangioma (DCH), which is typically associated with Sturge–Weber syndrome. While both forms are benign, they can significantly affect vision due to associated retinal changes.

Epidemiologically, CCH is rare, and DCH is even rarer. CCH typically presents in adulthood, often between the third and sixth decades of life, whereas DCH tends to present earlier, often in childhood or adolescence. There are no known genetic risk factors for CCH, while DCH occurs as part of Sturge–Weber syndrome, a sporadic neurocutaneous disorder characterized by vascular malformations involving the skin, brain, and eye.
The pathophysiology involves proliferation of thin-walled vascular channels within the choroid. These vascular spaces can leak fluid, leading to accumulation of subretinal fluid and serous retinal detachment. Chronic leakage may result in retinal pigment epithelium (RPE) changes, photoreceptor damage, and eventual visual impairment.

Clinically, patients often present with painless visual loss or metamorphopsia. On examination, circumscribed choroidal hemangioma appears as a unilateral, round or oval, orange-red elevated lesion located posterior to the equator. It is frequently associated with serous retinal detachment and overlying retinal changes such as edema or RPE alterations. Diffuse choroidal hemangioma, in contrast, presents as widespread thickening of the choroid, giving a characteristic “tomato ketchup” appearance of the fundus. In these cases, other ocular and systemic features of Sturge–Weber syndrome—such as episcleral vessel dilation and glaucoma—are often present.
​
Diagnostic evaluation includes multimodal imaging. Fluorescein angiography typically shows early hyperfluorescence with progressive leakage. Indocyanine green angiography demonstrates early intense hyperfluorescence followed by a characteristic “washout” pattern in later phases. Ultrasonography reveals a dome-shaped lesion with high internal reflectivity, similar to normal choroidal tissue. Optical coherence tomography is useful in detecting associated retinal changes such as subretinal fluid or macular edema and is particularly helpful for monitoring treatment response.

Management depends on symptoms and the risk to vision. Asymptomatic lesions without vision-threatening complications can be observed. Treatment is indicated when there is subretinal fluid or involvement of the macula. Photodynamic therapy (PDT) with verteporfin is the treatment of choice for circumscribed lesions and is also effective in diffuse cases. Other options include external beam radiotherapy and plaque radiotherapy, particularly in cases not amenable to PDT. Laser photocoagulation and transpupillary thermotherapy are less commonly used due to higher risks of tissue damage.

Prognosis depends largely on the duration and extent of retinal involvement. Early treatment of vision-threatening lesions improves outcomes, while delayed treatment may result in permanent photoreceptor and RPE damage. Complications include persistent serous retinal detachment and, in advanced cases, neovascular glaucoma, which can lead to severe vision loss and may require enucleation. Regular follow-up is essential to monitor for recurrence or progression.

​

Ophthalmology – Choroidal Effusion / Detachment
Choroidal effusion or detachment refers to the accumulation of fluid, either serous or hemorrhagic, in the suprachoroidal space. It occurs when fluid or blood collects between the choroid and sclera due to altered pressure relationships or increased vascular permeability. These detachments may occur after trauma, during or after ocular surgery, or more rarely, spontaneously. Serous detachments are often less dramatic in presentation, whereas hemorrhagic choroidal detachments can be painful and visually devastating.

The incidence varies widely, reported between 0.05% and 6%, depending on the clinical setting. There is no clear racial or sex predilection, although hemorrhagic choroidal detachments are more common in elderly patients. Risk factors for serous choroidal effusion include nanophthalmos, uveal effusion syndrome, carotid-cavernous fistula, intraocular inflammation, hypotony, trauma, scleritis, Vogt-Koyanagi-Harada syndrome, tumors, and certain medications. Hemorrhagic detachments are associated with older age, arteriosclerosis, systemic hypertension, uncontrolled glaucoma, myopia, prior ocular surgery, sickle cell disease, and a history of choroidal hemorrhage in the fellow eye. Surgical risk factors include wound leaks, scleral perforation, cyclodialysis clefts, leaking blebs, and prior laser or cryotherapy.
​
The pathophysiology depends on changes in the balance among intraocular pressure, vascular hydrostatic pressure, and oncotic pressure within the suprachoroidal space. Increased vascular permeability allows serum proteins and fluid to exude into this potential space, causing choroidal edema and detachment. In many cases, hypotony is a major precipitating factor. Hemorrhagic detachments occur when blood enters the same space, often after a sudden pressure change or vessel rupture.
Clinically, serous choroidal effusions often cause painless decreased vision and are frequently associated with low intraocular pressure, a shallow anterior chamber, and mild anterior chamber inflammation. On fundus examination, they appear as smooth, bullous, orange elevations of the choroid and retina, often extending circumferentially in the periphery with a lobulated contour. In contrast, hemorrhagic choroidal detachments usually present suddenly with severe pain, marked vision loss, a red eye, and are often associated with elevated intraocular pressure. A careful history should assess for recent surgery, trauma, laser treatment, straining, coughing, Valsalva, and the use of anticoagulants or aspirin.

On examination, it is important to look for evidence of a wound leak, filtering bleb, cyclodialysis cleft, or signs of recent ocular intervention. Seidel testing and gonioscopy may be helpful in identifying the source of hypotony. In selected cases, scalp and skin examination may help identify associated systemic inflammatory disease, such as vitiligo or alopecia in Vogt-Koyanagi-Harada syndrome.

B-scan ultrasonography is the most useful diagnostic tool and typically shows dome-shaped choroidal elevations with low-to-medium internal reflectivity. It helps distinguish serous from hemorrhagic detachments, assesses whether blood is mobile or clotted, and identifies severe appositional detachments known as “kissing choroidals.” Additional imaging such as CT or MRI may help differentiate choroidal effusion from tumors like choroidal melanoma. Transillumination may be positive in serous detachments, whereas hemorrhagic detachments typically do not transilluminate.

Management depends on the underlying cause. Initial treatment includes topical corticosteroids and cycloplegics, along with intraocular pressure control using topical or systemic medications. Oral steroids may be considered when inflammation is a contributing factor. Parasympathomimetic agents are contraindicated as they may worsen the condition.
Surgical intervention may be required if the detachment persists or is severe. Options include posterior sclerotomy to drain suprachoroidal fluid, anterior chamber paracentesis, or injection of viscoelastic substances if the anterior chamber is shallow or flat.

Prognosis depends largely on the underlying etiology. While there is no associated mortality, up to 40% of patients may experience significant vision loss. Hemorrhagic choroidal detachments generally carry a worse prognosis. Potential complications include retinal detachment, cataract formation, glaucoma, corneal endothelial damage, peripheral anterior synechiae, and in severe cases, phthisis bulbi.

​

Ophthalmology – Child Abuse
Child abuse and neglect, as defined by the Child Abuse Prevention and Treatment Act (CAPTA), refers to any act or failure to act by a caregiver that results in death or serious physical or emotional harm to a child. This includes physical abuse, neglect, and sexual exploitation. In ophthalmology, particular importance is given to abusive head trauma, including shaken baby syndrome (SBS), which is characterized by retinal hemorrhages, intracranial bleeding, and brain injury, often with minimal external signs of trauma. Neglect involves failure to provide essential needs such as food, shelter, supervision, medical care, and education.

Epidemiologically, child abuse remains a major public health concern. Millions of cases are reported annually, with hundreds of thousands confirmed and thousands of deaths each year. Infants and very young children are at the highest risk, particularly those under one year of age. While abuse affects all demographics, certain populations show higher risk rates. Most perpetrators are caregivers, often parents, and contributing factors include social stressors, substance abuse, and underlying family instability.

The pathophysiology of abusive head trauma involves rotational acceleration–deceleration forces that lead to tearing of bridging veins, causing subdural and subarachnoid hemorrhages, as well as diffuse axonal brain injury. Ocular findings result from vitreoretinal traction, producing extensive retinal hemorrhages that are often multilayered and extend to the peripheral retina. In severe cases, traction may also cause retinoschisis and retinal folds. These ocular findings are highly suggestive of abuse, especially when they are numerous and extend beyond the posterior pole.

The diagnosis of child abuse requires a high index of suspicion. Retinal hemorrhages are present in the majority of shaken baby syndrome cases and are often too numerous to count. Clinically, concern should arise when there is a delay in seeking care, inconsistent or changing history, or injuries that are not developmentally plausible. A detailed and carefully documented history is essential, including a clear timeline of events.

On physical examination, a complete systemic evaluation is necessary. Ocular examination with dilated funduscopy is critical and should be performed promptly by an ophthalmologist. Findings may include preretinal, intraretinal, or subretinal hemorrhages, often extending to the ora serrata. Retinoschisis with associated retinal folds is particularly indicative of abusive trauma. Other ocular signs such as hyphema, lens dislocation, or periocular bruising should raise suspicion in the absence of a clear accidental cause. Documentation, including detailed descriptions and photographs when available, is essential for both medical and legal purposes.

Diagnostic evaluation includes imaging and laboratory studies guided by clinical findings. Neuroimaging with CT or MRI often reveals subdural hematomas, cerebral edema, or diffuse axonal injury. A full skeletal survey is recommended in young children to identify occult fractures, especially rib and long bone injuries. Laboratory testing may be used to rule out alternative diagnoses such as coagulopathies or metabolic disorders. While retinal photography can assist in documentation, it does not replace a thorough clinical examination.
​
Management of suspected child abuse is multidisciplinary and urgent. Immediate priorities include stabilization of any life-threatening conditions. Hospitalization is often required for both medical evaluation and protection of the child. Physicians are legally mandated to report suspected abuse to child protective services, even if the diagnosis is not definitively proven. Long-term care involves coordination between medical providers, social services, and mental health professionals to address the needs of the child and family.
Prognosis depends on the severity of injury. Mortality rates in abusive head trauma range from 15% to 38%, and survivors often suffer long-term neurologic and visual complications. These may include cortical visual impairment, optic atrophy, amblyopia, and developmental delays. Severe brain injury correlates strongly with poor visual outcomes. Complications can be profound, including permanent disability, seizures, cerebral palsy, and in the worst cases, death.

​